Title:
Microfluidic particle-analysis systems
Document Type and Number:
Kind Code:
A1

Abstract:
The invention provides systems, including apparatus, methods, and kits, for the microfluidic manipulation and/or detection of particles, such as cells and/or beads. The invention provides systems, including apparatus, methods, and kits, for the microfluidic manipulation and/or analysis of particles, such as cells, viruses, organelles, beads, and/or vesicles. The invention also provides microfluidic mechanisms for carrying out these manipulations and analyses. These mechanisms may enable controlled input, movement/positioning, retention/localization, treatment, measurement, release, and/or output of particles. Furthermore, these mechanisms may be combined in any suitable order and/or employed for any suitable number of times within a system. Accordingly, these combinations may allow particles to be sorted, cultured, mixed, treated, and/or assayed, among others, as single particles, mixed groups of particles, arrays of particles, heterogeneous particle sets, and/or homogeneous particle sets, among others, in series and/or in parallel. In addition, these combinations may enable microfluidic systems to be reused. Furthermore, these combinations may allow the response of particles to treatment to be measured on a shorter time scale than was previously possible. Therefore, systems of the invention may allow a broad range of cell and particle assays, such as drug screens, cell characterizations, research studies, and/or clinical analyses, among others, to be scaled down to microfluidic size. Such scaled-down assays may use less sample and reagent, may be less labor intensive, and/or may be more informative than comparable macrofluidic assays.

Representative Image:
Inventors:
Chou, Hou-pu (Sunnyvale, CA, US)
Daridon, Antoine (Belmont, CA, US)
Farrell, Kevin (San Francisco, CA, US)
Fowler, Brian (Foster City, CA, US)
Liau, Yish-hann (San Jose, CA, US)
Manger, Ian D. (San Francisco, CA, US)
Nassef, Hany Ramez (San Mateo, CA, US)
Throndset, William (San Francisco, CA, US)
      Plaque It!

Application Number:
10/405953
Publication Date:
04/15/2004
Filing Date:
04/01/2003
View Patent Images:
Images are available in PDF form when logged in. To view PDFs, Login  or  Create Account (Free!)
Assignee:
Fluidigm Corporation (South San Francisco, CA)
Primary Class:
Other Classes:
436/63, 422/68.100, 435/29
International Classes:
(IPC1-7): C12M001/34; C12Q001/02; G01N033/00
Attorney, Agent or Firm:
TOWNSEND AND TOWNSEND AND CREW, LLP (TWO EMBARCADERO CENTER, SAN FRANCISCO, CA, 94111-3834, US)
Claims:

What is claimed is:



1. A microfluidic device for treating a particle comprising: (a) an input mechanism for introducing a fluid sample containing a particle; (b) a microfluidic passage in fluid communication with said input mechanism; (c) a positioning mechanism in fluid communication with said microfluidic passage, said positioning mechanism for positioning said particle in said microfluidic passage while contained in said fluid sample; (d) a retention mechanism for retaining said particle upon being positioned by said positioning means; (e) a treatment mechanism in communication with said retention mechanism for selectively treating said particle to produce a treatment response while being retained within said retention mechanism; and, (f) a measurement mechanism for measuring said treatment response, if any, of said particle.

2. The microfluidic device of claim 1 further comprising a release mechanism for releasing said particle from said retention mechanism.

3. The microfluidic device of claim 2 further comprising an output mechanism for outputting said particle from said microfluidic device.

4. The microfluidic device of claim 2 further comprising a cell culture mechanism for culturing said particle.

5. The microfluidic device of claim 1 further comprising a control mechanism for determining aspects of the flow rate or path of the sample fluid or other fluid.

6. The microfluidic device of claim 5, wherein said control mechanism is a valve in communication with said microfluidic passage.

7. The microfluidic device of claim 6, wherein said microfluidic device is formed from a multi-layer elastomeric block and, wherein said valve is formed from an elastomeric membrane within said elastomeric block.

8. The microfluidic device of claim 6, wherein said control mechanism is a pump in communication with said microfluidic passage.

9. The microfluidic device of claim 8, wherein said microfluidic device is formed from a multi-layer elastomeric block and, wherein said pump is formed from an elastomeric membrane within said elastomeric block.

10. The microfluidic device of claim 1, wherein said microfluidic device comprises a multi-layered elastomeric block having a control layer having an elastomeric membrane deflectable into said microfluidic passage in a fluidic layer to determine the flow rate or path of a fluid in said microfluidic passage.

11. The microfluidic device of claim 1, wherein said microfluidic device comprises a layer including a material selected from the group consisting of elastomers, polydimethylsiloxane, plastic, polystyrene, polypropylene, polycarbonate, glass, ceramic, silicon, sol-gels, metal, metalloids, metal oxides, biological polymers, mixtures thereof, particles, proteins, gelatins, polylysine, serum albumin, collagen, nucleic acids, and microoganisms.

12. The microfluidic device of claim 1, wherein said microfluidic passage has is less than about 500 micrometers wide.

13. The microfluidic device of claim 1, wherein said microfluidic passage further comprises an adjacent passage joining said microfluidic passage at a junction or branch, said adjacent passage being selected from the group consisting of inlet passage, outlet passage, particle passage, reagent passage, and waste passage.

14. The microfluidic device of claim 13, wherein said adjacent passage is a dead-end passage.

15. The microfluidic device of claim 13 further comprising said adjacent passage manipulating said particle.

16. The microfluidic device of claim 15, wherein said particle manipulating is selected from the group of positioning, sorting, retaining, treating, detecting, propagating, storing, mixing, and releasing.

17. The microfluidic device of claim 1, wherein said particle is selected from the group consisting of cells, eukaryotic cells, prokaryotic cells, plant cells, animal cells, hybridoma cells, bacterial cells, yeast cells, viruses, organelles, beads, and vesicles.

18. The microfluidic device of claim 17, wherein said particle is a plurality or an aggregate of particles.

19. The microfluidic device of claim 18, wherein said plurality of particles is a complex mixture containing different particles.

20. The microfluidic device of claim 19, wherein said complex mixture containing different particles is whole blood or serum or bodily fluid.

21. The microfluidic device of claim 1, wherein said particle is an egg or embryo.

22. The microfluidic device of claim 1, wherein the input mechanism is a receptacle or well in fluid communication with said microfluidic passage.

23. The microfluidic device of claim 22, wherein the input mechanism has a volume greater than a volume defined by said microfluidic passage.

24. The microfluidic device of claim 1 further comprising a facilitating mechanism in communication with or acting upon said input mechanism.

25. The microfluidic device of claim 24, wherein said facilitating mechanism is selected from the group consisting of gravity, fluid pressure, centrifugal pressure, pump pressure, and negative fluid pressure.

26. The microfluidic device of claim 1, wherein said positioning mechanism is a direct positioning mechanism or an indirect positioning mechanism.

27. The microfluidic device of claim 26, wherein said direct positioning mechanism is a force selected from the group consisting of optical, electrical, magnetic, and gravitational.

28. The microfluidic device of claim 27, wherein said electrical force is selected from the group consisting of electrophoretic, electroosmotic, electroendoosmotic, and dielectrophoretic.

29. The microfluidic device of claim 26, wherein said indirect positioning mechanism is a longitudinal indirect positioning mechanism or a transverse indirect positioning mechanism.

30. The microfluidic device of claim 29, wherein said indirect positioning mechanism is facilitated by a pump or a valve associated with said microfluidic device.

31. The microfluidic device of claim 29, wherein said transverse indirect positioning mechanism is facilitated by a fluid flow stream at a passage junction, laterally disposed region of reduced fluid flow, or channel bend.

32. The microfluidic device of claim 31, wherein said passage junction is unifying or dividing.

33. The microfluidic device of claim 29, wherein said transverse indirect positioning mechanism is a laminar flow-based transverse positioning means.

34. The microfluidic device of claim 29, wherein said transverse indirect positioning mechanism is a stochastic transverse positioning mechanism.

35. The microfluidic device of claim 34, wherein said stochastic transverse positioning mechanism randomly selects said particle from a population of particles by lateral separation of said particle in said sample fluid from a main flow region to a reduced flow region.

36. The microfluidic device of claim 29, wherein said transverse indirect positioning mechanism is a centrifugal forced-based transverse positioning mechanism.

37. The microfluidic device of claim 1 wherein said retention mechanism selectively retains said particle at a pre-selected region within said microfluidic device.

38. The microfluidic device of claim 37, wherein said retention mechanism retains said particle by overcoming or counteracting a force caused by said positioning mechanism.

39. The microfluidic device of claim 1, wherein said retention mechanism is a trap or barrier-based retention mechanism.

40. The microfluidic device of claim 39, wherein said barrier-based retention mechanism is restricts longitudinal movement of said particle in or adjacent said microfluidic passage.

41. The microfluidic device of claim 38, wherein said retention mechanism is a protrusion extending, fixedly or transiently, into or adjacent said microfluidic passage to restrict longitudinal movement of said particle.

42. The microfluidic device of claim 26, wherein said direct positioning mechanism is a chemical retention mechanism.

43. The microfluidic device of claim 42, wherein said chemical retention mechanism is based on a specific affinity between said particle and said retention mechanism.

44. The microfluidic device of claim 1, wherein said treatment mechanism is a fluid-mediated mechanism or a non-fluid mediated mechanism.

45. The microfluidic device of claim 1, wherein said treatment mechanism exposes said particle to a reagent or physical condition.

46. The microfluidic device of claim 45, wherein said reagent is selected from the group consisting of chemical modulator, biological modulator, agonist, antagonist, hormone, ligand, small molecule, peptide, protein, carbohydrate, lipid, receptor, nutrient, toxin, drug, chemical substance, compound, ion, polymer, nucleic acid, material, complex, mixture, aggregate, dye, stain, fluorescent dye, detection agent, assay agent, substrate, substrate inhibitor, antibody, labeled substance, and biological particle.

47. The microfluidic device of claim 46, wherein said reagent attracts or repels said particles.

48. The microfluidic device of claim 45, wherein said reagent induces or inhibits cell particle proliferation.

49. The microfluidic device of claim 45, wherein said reagent is cytotoxic.

50. The microfluidic device of claim 44, wherein said fluid-mediated mechanism further comprises a fluid treatment and wherein said particles are introduced to said fluid treatment.

51. The microfluidic device of claim 44, wherein said fluid-mediated mechanism functions in conjunction with the functioning of said positioning mechanism.

52. The microfluidic device of claim 51, wherein said positioning mechanism is a transverse positioning mechanism for moving said particle into and out of said fluid-mediated mechanism to modulate exposure of said particle to said treatment fluid.

53. The microfluidic device of claim 45, wherein said physical condition is selected from the group consisting of heat, light, radiation, sub-atomic particles, electric fields, magnetic fields, pressure, acoustical pressure, gravity, and micro-gravity.

54. The microfluidic device of claim 1, wherein said measurement mechanism is a detector associated with said microfluidic device that detects a characteristic of said particle or caused by said particle.

55. The microfluidic device of claim 54, wherein said detector is selected from the group consisting of spectroscopes, electronic sensors, hydrodynamic sensors, imaging systems, and photon detectors.

56. The microfluidic device of claim 54, wherein said detector detects multiple values.

57. The microfluidic device of claim 54, wherein said detector employs a detection mode that is selected from the group consisting of time-independent, time-dependent, and averaged.

58. The microfluidic device of claim 54, wherein said detector is a spectroscopic detector that detects a signal produced of a type selected from the group consisting of absorption, luminescence, photoluminescence, chemiluminescence, electroluminescence, magnetic resonance, nuclear resonance, electron spin resonance, scattering, electron scattering, light scattering, neutron scattering, diffraction, circular dichroism, optical rotation, fluorescence intensity, fluorescence resonance energy transfer, fluorescence polarization, fluorescence lifetime, total internal reflection fluorescence, fluorescence correlation spectroscopy, fluorescence recovery after photobleaching, fluorescence activated cell sorting, and phosphorescent.

59. The microfluidic device of claim 54, wherein said detector is an electrical detector capable of detecting a signal selected from the group consisting of current, voltage, resistance, capacitance, and power.

60. The microfluidic device of claim 54, wherein said detector is a hydrodynamic detector which detects a hydrodynamic interaction between said particle and a fluid, another particle, or said microfluidic passage.

61. The microfluidic device of claim 60, wherein said interaction included a hydrodynamic interaction selected from the group consisting of chromatography, sedimentation, viscometry, electrophoresis.

62. The microfluidic device of claim 54, wherein said detector is an imaging detector for creating and analyzing images of said particle(s).

63. The microfluidic device of claim 54, wherein said detector detects a biological response produced by said particle(s).

64. The microfluidic device of claim 63, wherein said biological response is selected from the group consisting of chemotaxis, biotaxis, senescence, apoptosis, proliferation, differentiation, morphological change, pH change, and calcium uptake.

65. The microfluidic device of claim 1, further comprising a detection site, wherein said particle or product of said particle, is detected by said detector.

66. The microfluidic device of claim 65, wherein said detection site is within said microfluidic device.

67. The microfluidic device of claim 65, wherein said detection site is located external to said microfluidic device.

68. The microfluidic device of claim 54, wherein said detector detects a characteristic of said particle, directly or indirectly, said characteristic being selected from the group consisting of particle identity, particle number, particle concentration, composition, structure, sequence, activity, molecular character, morphology, phenotype, genotype, growth, apoptosis, necrosis, lysis, alive/dead ratio, position in cell cycle, activity of signal pathway, differentiation, transcriptional activity, substrate attachment, cell-cell interaction, translational activity, replication activity, transformation, heat shock response, motility, spreading, membrane integrity, chemotaxis, and neurite outgrowth.

69. The microfluidic device of claim 2, wherein said release mechanism operates by removing a retaining force caused by said retaining mechanism.

70. The microfluidic device of claim 2, wherein said release mechanism operates by overcoming a retaining force caused by said retaining mechanism.

71. The microfluidic device of claim 2, wherein said release mechanism operates by rendering ineffective a retaining force caused by said retaining mechanism.

72. The microfluidic device of claim 2, further comprising directing said particle to another region within or external said microfluidic device.

73. The microfluidic device of claim 72, wherein said another region is selected from the group consisting of a second positioning mechanism, a second detection mechanism, a second retention mechanism, and an output mechanism.

74. The microfluidic device of claim 73, wherein said second retention mechanism is a cell culture chamber.

75. The microfluidic device of claim 3, further comprising said output mechanism outputting said particle to a location selected from the group consisting of an internal sink, and external sink, a waste site, a collection site, a cell growth chamber, and an external cell culture plate.

76. A method for perfusing cells with a reagent comprising the steps of: (a) providing a microfluidic device having (i) a cell growth chamber, a cell inlet in communication with said chamber, said cell inlet having an in valve in operable communication therewith to valve fluid flow through said cell inlet into said chamber, wherein said cells can pass through said cell inlet into said chamber when said inlet valve is open, but cannot pass through said cell inlet when said inlet valve is closed; and, (ii) a reagent inlet for inputting said reagent into said chamber, said reagent inlet having a reagent valve in operable communication with said reagent inlet for valving fluid flow through said reagent into said chamber, said inlet or said chamber having an retention mechanism for retaining said cells in said chamber while permitting flow of said reagent into said chamber when said reagent valve is open; wherein when said cells are loaded into said chamber, and said cell valve is closed, said cells are retained in said chamber while said reagent valve is open and closed; (b) opening said cell inlet valve and introducing said cells into said chamber; (c) closing said cell inlet valve; (d) opening said reagent valve to introduce said reagent into said chamber; and, (e) introducing said reagent into said chamber while retaining said cells inside of said chamber thereby perfusing said cells with said reagent.

77. A method for treating a particle comprising the steps of: (i) providing a microfluidic device comprising: (a) an input mechanism for introducing a fluid sample containing a particle; (b) a microfluidic passage in fluid communication with said input mechanism; (c) a positioning mechanism in fluid communication with said microfluidic passage, said positioning mechanism for positioning said particle in said microfluidic passage while contained in said fluid sample; (d) a retention mechanism for retaining said particle upon being positioned by said positioning means; (e) a treatment mechanism in communication with said retention mechanism for selectively treating said particle to produce a treatment response while being retained within said retention mechanism; and, (f) a measurement mechanism for measuring said treatment response, if any, of said particle. (ii) introducing said sample fluid containing said particle into said input mechanism; (iii) positioning said particle with said positioning mechanism so that said particle is retainable by said retention mechanism; (iv) retaining said particle with said retaining mechanism; (v) exposing said particle to said treatment by said treatment mechanism; (vi) measuring said treatment response caused directly or indirectly by said particle upon exposure to said treatment.

78. The method of claim 77 wherein said microfluidic device further comprises a release mechanism for releasing said particle from said retention mechanism, and said method further comprises the step of releasing said particle from said retaining mechanism.

79. The method of claim 78, wherein said microfluidic device further comprises an output mechanism for outputting said particle from said microfluidic device, and said method further comprises the step of outputting said particle from said microfluidic device by said output mechanism.

80. The method of claim 78, wherein said microfluidic device further comprises a cell culture mechanism for culturing said particle, and the method further comprises the step of culturing said particle in said cell culture mechanism.

81. The method of claim 77, wherein said microfluidic device further comprises a control mechanism for determining aspects of the flow rate or path of the sample fluid or other fluid, and the method further comprises the step of determining the flow rate or path of the sample fluid or other fluid by said control mechanism.

82. The method of claim 81, wherein said control mechanism is a valve in communication with said microfluidic passage, and the method further comprises valving said sample fluid or other fluid with said valve.

83. The microfluidic device of claim 82, wherein said microfluidic device is formed from a multi-layer elastomeric block and, wherein said valve is formed from an elastomeric membrane within said elastomeric block, and wherein said valving occurs by deflecting said elastomeric membrane into said microfluidic passage.

84. The method of claim 82, wherein said control mechanism is a pump in communication with said microfluidic passage, and wherein said determining the flow rate or path of said sample fluid occurs by actuation of said pump.

85. The method of claim 84, wherein said microfluidic device is formed from a multi-layer elastomeric block and, wherein said pump is formed from an elastomeric membrane within said elastomeric block, and wherein said pump is actuated by deflecting a series of elastomeric membranes into said microfluidic passage in a selected sequence.

86. The method of claim 77, wherein said microfluidic device comprises a multi-layered elastomeric block having a control layer having an elastomeric membrane deflectable into said microfluidic passage in a fluidic layer to selectively determine the flow rate or path of a fluid in said microfluidic passage.

87. The method of claim 77, wherein said microfluidic passage further comprises an adjacent passage joining said microfluidic passage at a junction or branch, said adjacent passage being selected from the group consisting of inlet passage, outlet passage, particle passage, reagent passage, and waste passage, and said method further comprises the step of selectively determining the path of said particle to said adjacent passage.

88. The method of claim 87, wherein said adjacent passage is a dead-end passage, and wherein said selectively determining includes introducing said sample fluid into said dead-end passage wherein said sample fluid displaces gas, if present, in said dead-end passage to fill said dead-end passage with said sample fluid.

89. The method of claim 87 further comprising said adjacent passage manipulating said particle.

90. The method of claim 89, wherein said particle manipulating includes retaining said particle in addition to either positioning, sorting, treating, detecting, propagating, storing, mixing, or releasing said particle.

91. The method of claim 77, wherein said particle is selected from the group consisting of cells, eukaryotic cells, prokaryotic cells, plant cells, animal cells, hybridoma cells, bacterial cells, yeast cells, viruses, organelles, beads, and vesicles, and wherein said treating step treats said particle.

92. The method of claim 91, wherein said particle is a plurality or an aggregate of particles, and said method further comprises a sorting step to sort out and separate or isolate a desired particle from said plurality of particles, and said treating step treats said separated or isolated particle.

93. The method of claim 92, wherein said plurality of particles is a complex mixture containing different particles, and said sorting step sorts out at least one type of particle from other different particles in said complex mixture.

94. The method of claim 93, wherein said complex mixture containing different particles is whole blood or serum or bodily fluid, and said sorting step selects for at least one type of cell from the whole blood or serum.

95. The method of claim 77, wherein said particle is an egg or embryo, and said treatment is a step towards in-vitro fertilizing or manipulating said egg or embryo, respectively.

96. The method of claim 77, wherein the input mechanism is a receptacle or well in fluid communication with said microfluidic passage, and said method further comprises the step of introducing said fluid sample into said receptacle.

Description:

CLAIM OF PRIORITY

[0001] This application claims the benefit of priority under 35 U.S.C. §119(e) to provisional applications Serial No. 60/369,538, filed Apr. 1, 2002 and 60/378,464, filed May 6, 2002, both of which are hereby incorporated by reference in their entirety for all purposes and those purposes stated herein and therein. This application further claims priority under 35 U.S.C. §120 as a continuation-in-part of the non-provisional patent application titled “Microfluidic Particle-Analysis Systems”, by Chou et al., filed on Mar. 31, 2003 (Atty. Docket No.: 139F.310US), which is hereby incorporated by reference for all purposes.

CROSS-REFERENCES TO PATENT APPLICATIONS

[0002] This application incorporates by reference in their entirety for all purposes the following U.S. patent applications: Ser. No. 09/605,520, filed Jun. 27, 2000; Ser. No. 09/724,784, filed Nov. 28, 2000; Ser. No. 09/724,967, filed Nov. 28, 2000; Ser. No. 09/796,378, filed Feb. 28, 2001; Ser. No. 09/796,666, filed Feb. 28, 2001; Ser. No. 09/796,871, filed Feb. 28, 2001; Ser. No. 09/826,583, filed Apr. 6, 2001; and Ser. No. 09/724,784, filed Nov. 28, 2001, titled MICROFABRICATED ELASTOMERIC VALVE AND PUMP SYSTEMS, and naming Marc A. Unger, Hou-Pu Chou, Todd A. Thorsen, Axel Scherer, Stephen R. Quake, Jian Liu, Mark L. Adams, and Carl L. Hansen as inventors.

CROSS-REFERENCES TO OTHER MATERIALS

[0003] This application incorporates by reference in their entirety for all purposes the following publications: Joe Sambrook and David Russell, Molecular Cloning: A Laboratory Manual (3 rd ed. 2000); and R. Ian Freshney, Culture of Animal Cells: A Manual of Basic Technique (4 th ed. 2000).

FIELD OF THE INVENTION

[0004] The invention relates to systems for the manipulation and/or detection of particles. More particularly, the invention relates to microfluidic systems for the manipulation and/or detection of particles, such as cells and/or beads.

BACKGROUND OF THE INVENTION

[0005] The ability to perform molecular and cellular analyses of biological systems has grown explosively over the past three decades. In particular, the advent and refinement of molecular and cellular techniques, such as DNA sequencing, gene cloning, monoclonal antibody production, cell transfection, amplification techniques (such as PCR), and transgenic animal formation, have fueled this explosive growth. These techniques have spawned an overwhelming number of identified genes, encoded proteins, engineered cell types, and assays for studying these genes, proteins, and cell types. As the number of possible combinations of samples, reagents, and assays becomes nearly incalculable, it has become increasingly apparent that novel approaches are necessary even to begin to make sense of this complexity, especially within reasonable temporal and monetary limitations.

[0006] One approach to these difficulties has been to reduce the scale of assays. Accordingly, substantial effort has been directed to developing assay methods and instrumentation for high-density microtiter plates. However, very small assay volumes in high-density microtiter plates, particularly assays with cells, may suffer from a number of shortcomings. For example, cells may be lost easily from wells, may be harmed by rapid fluid evaporation, may contaminate nearby wells, and may be difficult to remove efficiently from wells for additional analysis or culture. Thus, there is a need for systems that can effectively manipulate and analyze cells and other small particles, such as beads, in small volumes.

SUMMARY OF THE INVENTION

[0007] The invention provides systems, including apparatus, methods, and kits, for the microfluidic manipulation and/or detection of particles, such as cells and/or beads.

BRIEF DESCRIPTION OF THE DRAWINGS

[0008] FIG. 1 is a flow chart showing potential temporal relationships between method steps for manipulation and/or detection of particles in a microfluidic system, in accordance with aspects of the invention.

[0009] FIG. 2A is a top plan view of a microfluidic system for retaining and analyzing a subset of input particles, in accordance with aspects of the invention.

[0010] FIG. 2B is a top plan view of another microfluidic system for retaining and analyzing a subset of input particles, in accordance with aspects of the invention.

[0011] FIG. 3 is a fragmentary, top plan view of yet another microfluidic system for retaining and analyzing a subset of input particles, in accordance with aspects of the invention.

[0012] FIG. 4 is a view of the system of FIG. 3 during particle positioning and retention, illustrating the various flow paths followed by particles, in accordance with aspects of the invention.

[0013] FIG. 5 is a fragmentary, top plan view of a microfluidic system for positioning and retaining a group of particles, and for perfusing the retained group with selected reagents, in accordance with aspects of the invention.

[0014] FIG. 6 is a photographic image of a portion of a chip fabricated according to the system of FIG. 5 , in accordance with aspects of the invention.

[0015] FIG. 7 is a schematic rendition of the image of FIG. 6 , illustrating paths of fluid flow and particle movement relative to a particle-retention or capture chamber, in accordance with aspects of the invention.

[0016] FIG. 8 is a full top plan view of the system of FIG. 5 .

[0017] FIG. 9 is a photographic image of cells in a retention chamber, after exposure to Trypan blue to stain lysed cells, but before cell fixation, in accordance with aspects of the invention.

[0018] FIG. 10 is another photographic image of the cells and chamber of FIG. 9 , after exposure to methanol to lyse and fix the cells, in accordance with aspects of the invention.

[0019] FIG. 11 is yet another photographic image of the cells and chamber of FIG. 9 , after exposure to 1) methanol to lyse and fix the cells, 2) Trypan blue to stain lysed cells, and 3) a wash buffer to remove excess Trypan blue, in accordance with aspects of the invention.

[0020] FIG. 11A is a fragmentary, top plan view of a microfluidic system for measuring cell-cell communication, based on a duplicated version of the system of FIG. 8 , in accordance with aspects of the invention.

[0021] FIG. 11B is a top plan view of selected portions of an alternative embodiment of the system of FIG. 11 A, in accordance with aspects of the invention.

[0022] FIG. 11C is a top plan view of a two-dimensional array of particle capture chambers that may be used in a microfluidic system, in accordance with aspects of the invention.

[0023] FIG. 12 is a fragmentary, top plan view of a microfluidic system for retaining and perfusing two sets of particles in parallel, in accordance with aspects of the invention.

[0024] FIG. 13 is a view of selected portions of the system of FIG. 12 , illustrating paths for fluid flow and particle movement relative to two adjacent retention chambers, in accordance with aspects of the invention.

[0025] FIG. 13A is a top plan view of a microfluidic system for retaining two particles at spaced sites in a channel and perfusing the retained particles with distinct reagents, in accordance with aspects of the invention.

[0026] FIG. 13B is a top plan view of selected portions of the system of FIG. 13 A, in accordance with aspects of the invention.

[0027] FIG. 13C is a top plan view of selected portions of an alternative embodiment of the system of FIG. 13 A, in accordance with aspects of the invention.

[0028] FIG. 13D is a photograph of two beads being exposed to green dye delivered by spaced treatment mechanisms, using a chip constructed according to the system of FIG. 13 A, in accordance with aspects of the invention.

[0029] FIG. 13E is another photograph of the two beads of FIG. 13D during exposure to a red dye and a green dye delivered by spaced treatment mechanisms, in accordance with aspects of the invention.

[0030] FIG. 13F is yet another photograph of the two beads of FIG. 13D during exposure to a red dye and a yellow dye delivered by spaced treatment mechanisms, in accordance with aspects of the invention.

[0031] FIG. 13G is a photograph of two cells held at separate retention sites in a chip constructed according to the system of FIG. 13 A, in accordance with aspects of the invention.

[0032] FIG. 13H is a photograph of the two cells of FIG. 13G during exposure to a blue dye delivered by spaced treatment mechanisms, in accordance with aspects of the invention.

[0033] FIG. 13I is a photograph of the two cells of FIG. 13G during treatment of only one of the cells with an organic fixative, in accordance with aspects of the invention.

[0034] FIG. 13J is a photograph of the two cells of FIG. 131 , after fixation of the one cell and during exposure to a blue dye, delivered by spaced treatment mechanisms, in accordance with aspects of the invention.

[0035] FIG. 13K is a photograph of two fluorescent beads held at two retention sites and individually exposed to a fluorescent and a chromophoric dye delivered by spaced treatment mechanisms, but without the use of a spacer buffer, using a chip constructed according to the system of FIG. 13 A, in accordance with aspects of the invention.

[0036] FIG. 13L is a fragmentary, top plan view of a microfluidic system having separately addressable sets of linear trap arrays, in accordance with aspects of the invention.

[0037] FIG. 14 is a top plan view of a microfluidic system for retaining an array of particles in series and for perfusing members of this array separately and in parallel, in accordance with aspects of the invention.

[0038] FIG. 15 is a top plan view of selected portions of the system of FIG. 14 , illustrating fluid-layer and control-layer networks for treating retained particles separately and in parallel, in accordance with aspects of the invention.

[0039] FIG. 16 is a top plan view of portions of a single retention network from the system of FIG. 14 , illustrating selected paths of fluid flow, in accordance with aspects of the invention.

[0040] FIG. 17 is a fragmentary, top plan view of a microfluidic device for forming an array of single particles or groups of particles, in accordance with aspects of the invention.

[0041] FIG. 18 is a pair of fragmentary, top plan schematic views of a microfluidic device for forming an array of retained particles that may be transferred to an array of separate sites, illustrating particle retention and transfer configurations, on the left and right respectively, in accordance with aspects of the invention.

[0042] FIG. 19 is a pair of fragmentary, top plan schematic views of another microfluidic device for forming an array of retained particles that may be transferred to an array of separate sites, illustrating particle retention and transfer configurations, on the left and right respectively, in accordance with aspects of the invention.

[0043] FIG. 20 is fragmentary, top plan schematic view of yet another microfluidic device for forming an array of retained particles that may be transferred to an array of separate sites, in accordance with aspects of the invention.

[0044] FIG. 21 is a composite of top plan and sectional views showing selected portions of a microfluidic system for retaining particles using a particle-retention chamber that is fully spaced from the floor of the system, in accordance with aspects of the invention.

[0045] FIG. 22 is a composite of top plan and sectional views, and a photographic image, showing selected portions of a microfluidic system for retaining particles using a particle-retention chamber that is partially spaced from the floor of the system, in accordance with aspects of the invention.

[0046] FIG. 23 is a composite of top plan and sectional views, and two photographic images, showing selected portions of another microfluidic system for retaining particles using a particle-retention chamber that is fully spaced from the floor of the system, in accordance with aspects of the invention.

[0047] FIG. 24 is a fragmentary, top plan view of a reusable microfluidic system for repeated retention, treatment, and release of single particles, in accordance with aspects of the invention.

[0048] FIG. 25 is a view of selected portions of the system of FIG. 24 , particularly a particle release mechanism, in accordance with aspects of the invention.

[0049] FIG. 26 is a fragmentary, top plan view of a reusable microfluidic system for repeated retention, treatment, and release of groups of particles, in accordance with aspects of the invention.

[0050] FIG. 27 is a view of selected portions of the systems of FIGS. 24 and 26 , particularly a particle collection mechanism, in accordance with aspects of the invention.

[0051] FIG. 28 is a fragmentary, top plan view of an input mechanism that includes a particle suspension mechanism, in accordance with aspects of the invention.

[0052] FIG. 29 is a fragmentary, top plan view of an adjustable dilution mechanism, in accordance with aspects of the invention.

[0053] FIG. 30 is a fragmentary, top plan view of another adjustable dilution mechanism, in accordance with aspects of the invention.

[0054] FIG. 31 is a top plan view of a microfluidic system having a sorting mechanism based on centrifugal force, in accordance with aspects of the invention.

[0055] FIG. 32 is a fragmentary view of the system of FIG. 31 , showing the sorting mechanism in greater detail, in accordance with aspects of the invention.

[0056] FIG. 33 is a fragmentary, top plan view of another microfluidic system having a sorting mechanism based on centrifugal force, in accordance with aspects of the invention.

[0057] FIG. 34 is a top plan view of a yet another microfluidic system having a sorting mechanism based on centrifugal force, in accordance with aspects of the invention.

[0058] FIG. 35 is a fragmentary view of the system of FIG. 34 , showing the sorting mechanism in greater detail.

[0059] FIG. 36 is a photographic image of fluorescent beads and particles being separated by the sorting mechanism of FIGS. 34 and 35 .

[0060] FIG. 37 is a graph plotting the ratio of cells to beads over time during sorting with the system of FIGS. 34 and 35 .

[0061] FIG. 38 is a graph plotting the ratio of cells to beads over time during sorting with the system of FIGS. 31 and 32 .

[0062] FIGS. 39 - 43 are top plan composite views of various cell-chamber networks for microfluidic manipulation of cells, in accordance with aspects of the invention.

[0063] FIG. 44 is a top plan view of a microfluidic system with a parallel array of separate, isolatable cell-chamber networks, in accordance with aspects of the invention.

[0064] FIG. 45 is a top plan view of a microfluidic system with an isolatable cell chamber that may be fed or bypassed by a parallel fluidic circuit, in accordance with aspects of the invention.

[0065] FIG. 46 is a top plan view of a microfluidic system having a cell chamber that forms a loop, in accordance with aspects of the invention

[0066] FIG. 47 is a top plan view of a microfluidic system in which particle and reagent networks intersect at a common cell chamber, in accordance with aspects of the invention.

[0067] FIGS. 48 and 49 are photographic images of filtering mechanisms with size-selective channels that are included in the reagent networks of chips fabricated according to the system of FIG. 47 .

[0068] FIG. 50 is a composite of two photographic images showing cells cultured in a cell chamber of a chip fabricated according to the system of FIG. 47 .

[0069] FIG. 50A is a fragmentary, top plan view of a system for depositing cells in a cell chamber, based on a nonlinear, asymmetrical flow path, in accordance with aspects of the invention.

[0070] FIG. 50B is a fragmentary, top plan view of a modified version of the system of FIG. 50 A, in which reagent(s) may be recirculated through the cell chamber, in accordance with aspects of the invention.

[0071] FIG. 50C is a top plan view of a cell chamber having two distinct compartments connected by a set of radially arrayed, size-selective channels, in accordance with aspects of the invention.

[0072] FIG. 50D is a top plan view of a version of the cell chamber of FIG. 50 C, modified to interconnect the two compartments more fully, in accordance with aspects of the invention.

[0073] FIG. 51 is an isometric schematic view of a microfluidic system for performing electrophysiological analysis on an array of cells, in accordance with aspects of the invention.

[0074] FIG. 52 is a top plan view of a microfluidic system for performing electrophysiological analysis on a single cell, in accordance with aspects of the invention.

[0075] FIG. 53 is a fragmentary top plan view of a microfluidic system related to the system of FIG. 52 , showing a modified focusing mechanism, in accordance with aspects of the invention.

[0076] FIG. 54 is a top plan view of selected portions of the system of FIG. 52 with a retained cell, in accordance with aspects of the invention.

[0077] FIG. 55 is a top plan view of selected portions of the system of FIG. 52 during perfusion of a retained cell, in accordance with aspects of the invention.

[0078] FIG. 56 is another top plan view of selected portions of the system of FIG. 52 , in accordance with aspects of the invention.

[0079] FIG. 57 is yet another top plan view of selected portions of the system of FIG. 52 , in accordance with aspects of the invention.

[0080] FIG. 58 is a photographic image of a portion of a chip fabricated according to the system of FIG. 52 .

[0081] FIG. 59 is an abstracted view of a microfluidic device for performing patch-clamp analysis of cells, in accordance with aspects of the invention.

[0082] FIG. 60 is a fragmentary top plan view of a microfluidic device for performing patch-clamp analysis of multiple individual cells, in accordance with aspects of the invention.

[0083] FIG. 61 is a graph showing 95% probability of successfully obtaining an electrophysiological reading as a function of both the number of apertures (channels) analyzed and the fraction of individual apertures that give a successful reading.

[0084] FIG. 62 is a fragmentary side elevation view of a microfluidic mold spin-coated with a first layer of patternable, selectively removable material, in accordance with aspects of the invention.

[0085] FIG. 63 is a fragmentary side elevation view of the mold of FIG. 62 after patterned removal of the first layer, in accordance with aspects of the invention.

[0086] FIG. 64 is a fragmentary side elevation view of the mold of FIG. 63 spin-coated with a second layer of patternable, selectively removable material, in accordance with aspects of the invention.

[0087] FIG. 65 is a fragmentary side elevation view of the mold of FIG. 64 after patterned removal of the second layer, in accordance with aspects of the invention.

[0088] FIG. 66 is a fragmentary side elevation view of the mold of FIG. 65 after heating at elevated temperatures to round remaining portions of the second layer, in accordance with aspects of the invention.

[0089] FIG. 67 is a fragmentary side elevation view of the mold of FIG. 66 spin-coated with a third layer of patternable, selectively removable material, in accordance with aspects of the invention.

[0090] FIG. 68 is a fragmentary side elevation view of the mold of FIG. 67 following patterned removal of the third layer, in accordance with aspects of the invention.

[0091] FIG. 69 is a fragmentary side elevation view of the mold of FIG. 68 acting to mold complementary surface features of a fluid-layer membrane, in accordance with aspects of the invention.

[0092] FIG. 70 is a composite of photographic images of 1) a fluid-layer mold formed using the method depicted in FIGS. 62 - 68 and 2) a corresponding molded chip formed from the fluid-layer mold, in accordance with aspects of the invention.

[0093] FIG. 71 is a composite of photographic images of 1) a fluid-layer mold formed using the method depicted in FIGS. 62 - 68 and 2) a corresponding molded chip formed partially from the fluid-layer mold, in accordance with aspects of the invention.

[0094] FIG. 71A is a graph of fluorescence emission versus time for a fluorophore being excited at different light intensities, in accordance with aspects of the invention.

[0095] FIG. 71B is a schematic diagram of an embodiment of a method for increasing the signal-to-noise ratio of a detected signal by modulation of an exciting light source and demodulation of the detected signal, based on the modulation, in accordance with aspects of the invention.

[0096] FIG. 71C is a pair of graphs of time-dependent measured noise and measured signal plus noise without (top) and with (bottom) implementation of the modulation-demodulation method of FIG. 71B in a microfluidic system, in accordance with aspects of the invention.

[0097] FIG. 71D is a graph of measured fluorescence intensity versus time prior to and during cycles of exposure of a biotinylated bead to a streptavidin-dye conjugate in a microfluidic system, in accordance with aspects of the invention.

[0098] FIG. 71E is a graph of measured fluorescence intensity versus time prior to and during exposure of ionomcyin to a retained cell that was preloaded with a calcium-sensor dye, using the method of FIG. 71B in a microfluidic system, in accordance with aspects of the invention.

[0099] FIG. 71F is a graph of measured fluorescence intensity versus time at a position in a microfluidic system prior to and during exposure to a dye, in accordance with aspects of the invention.

[0100] FIG. 72 is a time-lapse set of photographic images recording size-selective flow of blood cells through a microfluidic system, in accordance with aspects of the invention.

[0101] FIG. 73 is diagram showing the structure of biotin and its mode of binding to streptavidin.

[0102] FIG. 74 is a time-lapse set of photographic images recording interaction of specific binding pairs on beads in a microfluidic system, in accordance with aspects of the invention.

[0103] FIG. 75 is a time-lapse set of photographic images recording stimulation of ion flux in a microfluidic system, in accordance with aspects of the invention.

[0104] FIG. 76 is a time-lapse set of photographic images recording apoptosis and necrosis in a microfluidic system, in accordance with aspects of the invention.

[0105] FIGS. 77 and 78 are diagrams showing the structures and excitation/emission spectra for membrane dyes used in the analysis of Example 22.

[0106] FIG. 79 is a photographic image recording successful staining of a cell's membrane in a non-microfluidic environment.

[0107] FIG. 80 is a time-lapse set of photographic images recording retention of a single cell at a preselected site in a microfluidic system, in accordance with aspects of the invention.

[0108] FIG. 81 is a time-lapse set of photographic images recording retention of a group of cells at a preselected site in a microfluidic system, in accordance with aspects of the invention.

[0109] FIG. 82 is a time-lapse set of photographic images recording entry of a fluorescent cell into a retention chamber already holding several cells, in accordance with aspects of the invention.

[0110] FIG. 83 is a time-lapse set of photographic images recording fixation and staining of a retained cell in a microfluidic system, in accordance with aspects of the invention.

[0111] FIG. 84 is a top plan view of a microfluidic system for analyzing a size-selected set of cells, in which the system includes serially disposed filtration and retention mechanisms, a perfusion mechanism, and a flow-based detection mechanism, in accordance with aspects of the invention.

[0112] FIG. 85 is another top plan view of the microfluidic system of FIG. 84 , showing identifying labels for reservoirs and valves, in accordance with aspects of the invention.

[0113] FIG. 86 is a top plan view of selected portions of the system of FIG. 84 , illustrating selected aspects including a filtration mechanism, in accordance with aspects of the invention.

[0114] FIG. 87 is another top plan view of selected portions of the system of FIG. 84 , in accordance with aspects of the invention.

[0115] FIG. 88 is yet another top plan view of selected portions of the system of FIG. 84 , in accordance with aspects of the invention.

[0116] FIG. 89 is a top plan view of a perfusion device for exposing particles to an array of different reagents or different reagent concentrations.

[0117] FIGS. 90 through 94 depict a top plan view of a device being used to measure chemotactic response of cells to a chemoattractant.

[0118] FIG. 95 is a close-up top plan view of a perfusion chamber with associated valving system.

DETAILED DESCRIPTION

[0119] The invention provides systems, including apparatus, methods, and kits, for the microfluidic manipulation and/or analysis of particles, such as cells, viruses, organelles, beads, and/or vesicles. The invention also provides microfluidic mechanisms for carrying out these manipulations and analyses. These mechanisms may enable controlled input, movement/positioning, retention/localization, treatment, measurement, release, and/or output of particles. Furthermore, these mechanisms may be combined in any suitable order and/or employed for any suitable number of times within a system. Accordingly, these combinations may allow particles to be sorted, cultured, mixed, treated, and/or assayed, among others, as single particles, mixed groups of particles, arrays of particles, heterogeneous particle sets, and/or homogeneous particle sets, among others, in series and/or in parallel. In addition, these combinations may enable microfluidic systems to be reused. Furthermore, these combinations may allow the response of particles to treatment to be measured on a shorter time scale than was previously possible. Therefore, systems of the invention may allow a broad range of cell and particle assays, such as drug screens, cell characterizations, research studies, and/or clinical analyses, among others, to be scaled down to microfluidic size. Such scaled-down assays may use less sample and reagent, may be less labor intensive, and/or may be more informative than comparable macrofluidic assays.

[0120] Further aspects of the invention are described in the following sections: (I) microfluidic systems, (II) physical structures of fluid networks, (III) particles, (IV) input mechanisms, (V) positioning mechanisms, (VI) retention mechanisms, (VII) treatment mechanisms, (VIII) measurement mechanisms, (IX) release mechanisms, (X) output mechanisms, (XI) cell culture mechanisms, (XII) particle-based manipulations, and (XIII) examples.

[0121] Microfluidic Systems

[0122] Definitions and Overview

[0123] Particle manipulations and analyses are performed in microfluidic systems. A microfluidic system generally comprises any system in which very small volumes of fluid are stored and manipulated, generally less than about 500 μL, typically less than about 100 μL, and more typically less than about 10 μL. Microfluidic systems carry fluid in predefined paths through one or more microfluidic passages. A microfluidic passage may have a minimum dimension, generally height or width, of less than about 200, 100, or 50 μm. Passages are described in more detail below in Section II.

[0124] Microfluidic systems may include one or more sets of passages that interconnect to form a generally closed microfluidic network. Such a microfluidic network may include one, two, or more openings at network termini, or intermediate to the network, that interface with the external world. Such openings may receive, store, and/or dispense fluid. Dispensing fluid may be directly into the microfluidic network or to sites external the microfluidic system. Such openings generally function in input and/or output mechanisms, described in more detail in Sections IV and X below, and may include reservoirs, described in more detail in Section II below.

[0125] Microfluidic systems also may include any other suitable features or mechanisms that contribute to fluid, reagent, and/or particle manipulation or analysis. For example, microfluidic systems may include regulatory or control mechanisms that determine aspects of fluid flow rate and/or path. Valves and/or pumps that may participate in such regulatory mechanisms are described in more detail below in Section II. Alternatively, or in addition, microfluidic systems may include mechanisms that determine, regulate, and/or sense fluid temperature, fluid pressure, fluid flow rate, exposure to light, exposure to electric fields, magnetic field strength, and/or the like. Accordingly, microfluidic systems may include heaters, coolers, electrodes, lenses, gratings, light sources, pressure sensors, pressure transducers, microprocessors, microelectronics, and/or so on. Furthermore, each microfluidic system may include one or more features that act as a code to identify a given system. The features may include any detectable shape or symbol, or set of shapes or symbols, such as black-and-white or colored barcode, a word, a number, and/or the like, that has a distinctive position, identity, and/or other property (such as optical property).

[0126] Materials

[0127] Microfluidic systems may be formed of any suitable material or combination of suitable materials. Suitable materials may include elastomers, such as polydimethylsiloxane (PDMS); plastics, such as polystyrene, polypropylene, polycarbonate, etc.; glass; ceramics; sol-gels; silicon and/or other metalloids; metals or metal oxides; biological polymers, mixtures, and/or particles, such as proteins (gelatin, polylysine, serum albumin, collagen, etc.), nucleic acids, microorganisms, etc.; and/or the like.

[0128] Exemplary materials for microfluidic systems are described in more detail in the patent applications listed above under Cross-References, which are incorporated herein by reference.

[0129] Methods of Fabrication

[0130] Microfluidic systems, also referred to as chips, may have any suitable structure. Such systems may be fabricated as a unitary structure from a single component, or as a multi-component structure of two or more components. The two or more components may have any suitable relative spatial relationship and may be attached to one another by any suitable bonding mechanism.

[0131] In some embodiments, two or more of the components may be fabricated as relatively thin layers, which may be disposed face-to-face. The relatively thin layers may have distinct thickness, based on function. For example, the thickness of some layers may be about 10 to 250 μm, 20 to 200 μm, or about 50 to 150 μm, among others. Other layers may be substantially thicker, in some cases providing mechanical strength to the system. The thicknesses of such other layers may be about 0.25 to 2 cm, 0.4 to 1.5 cm, or 0.5 to 1 cm, among others. One or more additional layers may be a substantially planar layer that functions as a substrate layer, in some cases contributing a floor portion to some or all microfluidic passages.

[0132] Components of a microfluidic system may be fabricated by any suitable mechanism, based on the desired application for the system and on materials used in fabrication. For example, one or more components may be molded, stamped, and/or embossed using a suitable mold. Such a mold may be formed of any suitable material by micromachining, etching, soft lithography, material deposition, cutting, and/or punching, among others. Alternatively, or in addition, components of a microfluidic system may be fabricated without a mold by etching, micromachining, cutting, punching, and/or material deposition.

[0133] Microfluidic components may be fabricated separately, joined, and further modified as appropriate. For example, when fabricated as distinct layers, microfluidic components may be bonded, generally face-to-face. These separate components may be surface-treated, for example, with reactive chemicals to modify surface chemistry, with particle binding agents, with reagents to facilitate analysis, and/or so on. Such surface-treatment may be localized to discrete portions of the surface or may be relatively nonlocalized. In some embodiments, separate layers may be fabricated and then punched and/or cut to produce additional structure. Such punching and/or cutting may be performed before and/or after distinct components have been joined.

[0134] Exemplary methods for fabricating microfluidic systems are described in more detail in the patent applications identified above under Cross-References, which are incorporated herein by reference.

[0135] Physical Structures of Fluid Networks

[0136] Overview

[0137] Microfluidic systems may include any suitable structure(s) for the integrated manipulation of small volumes of fluid, including moving and/or storing fluid, and particles associated therewith, for use in particle assays. The structures may include passages, reservoirs, and/or regulators, among others.

[0138] Passages

[0139] Passages generally comprise any suitable path, channel, or duct through, over, or along which materials (e.g., fluid, particles, and/or reagents) may pass in a microfluidic system. Collectively, a set of fluidically communicating passages, generally in the form of channels, may be referred to as a microfluidic network. In some cases, passages may be described as having surfaces that form a floor, a roof, and walls. Passages may have any suitable dimensions and geometry, including width, height, length, and/or cross-sectional profile, among others, and may follow any suitable path, including linear, circular, and/or curvilinear, among others. Passages also may have any suitable surface contours, including recesses, protrusions, and/or apertures, and may have any suitable surface chemistry or permeability at any appropriate position within a channel. Suitable surface chemistry may include surface modification, by addition and/or treatment with a chemical and/or reagent, before, during, and/or after passage formation.

[0140] In some cases, passages, and particularly channels, may be described according to function. For example, passages may be described according to direction of material flow in a particular application, relationship to a particular reference structure, and/or type of material carried. Accordingly, passages may be inlet passages (or channels), which generally carry materials to a site, and outlet passages (or channels), which generally carry materials from a site. In addition, passages may be referred to as particle passages (or channels), reagent passages (or channels), focusing passages (or channels), perfusion passages (or channels), waste passages (or channels), and/or the like.

[0141] Passages may branch, join, and/or dead-end to form any suitable microfluidic network. Accordingly, passages may function in particle positioning, sorting, retention, treatment, detection, propagation, storage, mixing, and/or release, among others.

[0142] Further aspects of passages are included throughout this Detailed Description, and in the patent applications identified above under Cross-References, which are incorporated herein by reference.

[0143] Reservoirs

[0144] Reservoirs generally comprise any suitable receptacle or chamber for storing materials (e.g., fluid, particles and/or reagents), before, during, between, and/or after processing operations (e.g., measurement and/or treatment). Reservoirs, also referred to as wells, may include input, intermediate, and/or output reservoirs. Input reservoirs may store materials (e.g., fluid, particles, and/or reagents) prior to inputting the materials to a microfluidic network(s) portion of a chip. By contrast, intermediate reservoirs may store materials during and/or between processing operations. Finally, output reservoirs may store materials prior to outputting from the chip, for example, to an external processor or waste, or prior to disposal of the chip.

[0145] Further aspects of reservoirs are included in the patent applications identified above under Cross-References, which are incorporated herein by reference.

[0146] Regulators

[0147] Regulators generally comprise any suitable mechanism for generating and/or regulating movement of materials (e.g., fluid, particles, and/or reagents). Suitable regulators may include valves, pumps, and/or electrodes, among others. Regulators may operate by actively promoting flow and/or by restricting active or passive flow. Suitable functions mediated by regulators may include mixing, sorting, connection (or isolation) of fluidic networks, and/or the like.

[0148] Further aspects of regulators, particularly the structure, fabrication, and operation of valves and pumps, are included in the patent applications identified above under Cross-References, which are incorporated herein by reference, and in Section XIII, particularly Example 8.

[0149] Particles

[0150] Overview

[0151] Microfluidic systems may be used to manipulate and/or analyze particles. A particle generally comprises any object that is small enough to be inputted and manipulated within a microfluidic network in association with fluid, but that is large enough to be distinguishable from the fluid. Particles, as used here, typically are microscopic or near-microscopic, and may have diameters of about 0.005 to 100 μm, 0.1 to 50 μm, or about 0.5 to 30 μm. Alternatively, or in addition, particles may have masses of about 10 −20 to 10 −5 grams, 10 −16 to 10 −7 grams, or 10 −14 to 10 −8 grams. Exemplary particles may include cells, viruses, organelles, beads, and/or vesicles, and aggregates thereof, such as dimers, trimers, etc.

[0152] Cells

[0153] Overview

[0154] Cells, as used here, generally comprise any self-replicating, membrane-bounded biological entity, or any nonreplicating, membrane-bounded descendant thereof. Nonreplicating descendants may be senescent cells, terminally differentiated cells, cell chimeras, serum-starved cells, infected cells, nonreplicating mutants, anucleate cells, etc.

[0155] Cells used as particles in microfluidic systems may have any suitable origin, genetic background, state of health, state of fixation, membrane permeability, pretreatment, and/or population purity, among others. Origin of cells may be eukaryotic, prokaryotic, archae, etc., and may be from animals, plants, fungi, protists, bacteria, and/or the like. Cells may be wild-type; natural, chemical, or viral mutants; engineered mutants (such as transgenics); and/or the like. In addition, cells may be growing, quiescent, senescent, transformed, and/or immortalized, among others, and cells may be fixed and/or unfixed. Living or dead, fixed or unfixed cells may have intact membranes, and/or permeabilized/disrupted membranes to allow uptake of ions, labels, dyes, ligands, etc., or to allow release of cell contents. Cells may have been pretreated before introduction into a microfluidic system by any suitable processing steps. Such processing steps may include modulator treatment, transfection (including infection, injection, particle bombardment, lipofection, coprecipitate transfection, etc.), processing with assay reagents, such as dyes or labels, and/or so on. Furthermore, cells may be a monoculture, generally derived as a clonal population from a single cell or a small set of very similar cells; may be presorted by any suitable mechanism such as affinity binding, FACS, drug selection, etc.; and/or may be a mixed or heterogeneous population of distinct cell types.

[0156] Eukaryotic Cells

[0157] Eukaryotic cells, that is, cells having one or more nuclei, or anucleate derivatives thereof, may be obtained from any suitable source, including primary cells, established cells, and/or patient samples. Such cells may be from any cell type or mixture of cell types, from any developmental stage, and/or from any genetic background. Furthermore, eukaryotic cells may be adherent and/or nonadherent. Such cells may be from any suitable eukaryotic organism including animals, plants, fungi, and/or protists.

[0158] Eukaryotics cells may be from animals, that is, vertebrates or invertebrates. Vertebrates may include mammals, that is, primates (such as humans, apes, monkeys, etc.) or nonprimates (such as cows, horses, sheep, pigs, dogs, cats, marsupials, rodents, and/or the like). Nonmammalian vertebrates may include birds, reptiles, fish, (such as trout, salmon, goldfish, zebrafish, etc.), and/or amphibians (such as frogs of the species Xenopus, Rana, etc.). Invertebrates may include arthropods (such as arachnids, insects (e.g., Drosophila), etc.), mollusks (such as clams, snails, etc.), annelids (such as earthworms, etc.), echinoderms (such as various starfish, among others), coelenterates (such as jellyfish, coral, etc.), porifera (sponges), platyhelminths (tapeworms), nemathelminths (flatworms), etc.

[0159] Eukaryotic cells may be from any suitable plant, such as monocotyledons, dicotyledons, gymnosperms, angiosperms, ferns, mosses, lichens, and/or algae, among others. Exemplary plants may include plant crops (such as rice, corn, wheat, rye, barley, potatoes, etc.), plants used in research (e.g., Arabadopsis, loblolly pine, etc.), plants of horticultural values (ornamental palms, roses, etc.), and/or the like.

[0160] Eukaryotic cells may be from any suitable fungi, including members of the phyla Chytridiomycota, Zygomycota, Ascomycota, Basidiomycota, Deuteromycetes, and/or yeasts. Exemplary fungi may include Saccharomyces cerevisiae, Schizosaccharomyces pombe, Pichia pastoralis, Neurospora crassa , mushrooms, puffballs, imperfect fungi, molds, and/or the like.

[0161] Eukaryotic cells may be from any suitable protists (protozoans), including amoebae, ciliates, flagellates, coccidia, microsporidia, and/or the like. Exemplary protists may include Giardia lamblia, Entamoeba. histolytica , Cryptosporidium, and/or N. fowleri , among others.

[0162] Particles may include eukaryotic cells that are primary, that is, taken directly from an organism or nature, without subsequent extended culture in vitro. For example, the cells may be obtained from a patient sample, such as whole blood, packed cells, white blood cells, urine, sputum, feces, mucus, spinal fluid, tumors, diseased tissue, bone marrow, lymph, semen, pleural fluid, a prenatal sample, an aspirate, a biopsy, disaggregated tissue, epidermal cells, keratinocytes, endothelial cells, smooth muscle cells, skeletal muscle cells, neural cells, renal cells, prostate cells, liver cells, stem cells, osteoblasts, and/or the like. Similar samples may be manipulated and analyzed from human volunteers, selected members of the human population, forensic samples, animals, plants, and/or natural sources (water, soil, air, etc.), among others.

[0163] Alternatively, or in addition, particles may include established eukaryotic cells. Such cells may be immortalized and/or transformed by any suitable treatment, including viral infection, nucleic acid transfection, chemical treatment, extended passage and selection, radiation exposure, and/or the like. Such established cells may include various lineages such as neuroblasts, neurons, fibroblasts, myoblasts, myotubes, chondroblasts, chondrocytes, osteoblasts, osteocytes, cardiocytes, smooth muscle cells, epithelial cells, keratinocytes, kidney cells, liver cells, lymphocytes, granulocytes, and/or macrophages, among others. Exemplary established cell lines may include Rat-1, NIH 3T3, HEK 293, COS1, COS7, CV-1, C2C12, MDCK, PC12, SAOS, HeLa, Schneider cells, Junkat cells, SL2, and/or the like.

[0164] Prokaryotic Cells

[0165] Particles may be prokaryotic cells, that is, self-replicating, membrane-bounded microorganisms that lack membrane-bound organelles, or nonreplicating descendants thereof. Prokaryotic cells may be from any phyla, including Aquificae, Bacteroids, Chlorobia, Chrysogenetes, Cyanobacteria, Fibrobacter, Firmicutes, Flavobacteria, Fusobacteria, Proteobacteria, Sphingobacteria, Spirochaetes, Thermomicrobia, and/or Xenobacteria, among others. Such bacteria may be gram-negative, gram-positive, harmful, beneficial, and/or pathogenic. Exemplary prokaryotic cells may include E. coli, S. typhimurium, B. subtilis, S. aureus, C. perfringens, V. parahaemolyticus , and/or B. anthracis , among others.

[0166] Viruses

[0167] Viruses may be manipulated and/or analyzed as particles in microfluidic systems. Viruses generally comprise any microscopic/submicroscopic parasites of cells (animals, plants, fungi, protists, and/or bacteria) that include a protein and/or membrane coat and that are unable to replicate without a host cell. Viruses may include DNA viruses, RNA viruses, retroviruses, virions, viroids, prions, etc. Exemplary viruses may include HIV, RSV, rabies, hepatitis virus, Epstein-Barr virus, rhinoviruses, bacteriophages, prions that cause various diseases (CJD (Creutzfeld-Jacob disease, kuru, GSS (Gerstmann-Straussler-Scheinker syndrome), FFI (Fatal Familial Insomnia), Alpers syndrome, etc.), and/or the like.

[0168] Organelles

[0169] Organelles may be manipulated and/or analyzed in microfluidic systems. Organelles generally comprise any particulate component of a cell. For example, organelles may include nuclei, Golgi apparatus, lysosomes, endosomes, mitochondria, peroxisomes, endoplasmic reticulum, phagosomes, vacuoles, chloroplasts, etc.

[0170] Beads

[0171] Particle assays may be performed with beads. Beads generally comprise any suitable manufactured particles. Beads may be manufactured from inorganic materials, or materials that are synthesized chemically, enzymatically and/or biologically. Furthermore, beads may have any suitable porosity and may be formed as a solid or as a gel. Suitable bead compositions may include plastics (e.g., polystyrene), dextrans, glass, ceramics, sol-gels, elastomers, silicon, metals, and/or biopolymers (proteins, nucleic acids, etc.). Beads may have any suitable particle diameter or range of diameters. Accordingly, beads may be a substantially uniform population with a narrow range of diameters, or beads may be a heterogeneous population with a broad range of diameters, or two or more distinct diameters.

[0172] Beads maybe associated with any suitable materials. The materials may include compounds, polymers, complexes, mixtures, phages, viruses, and/or cells, among others. For example, the beads may be associated with a member of a specific binding pair (see Section VI), such as a receptor, a ligand, a nucleic acid, a member of a compound library, and/or so on. Beads may be a mixture of distinct beads, in some cases carrying distinct materials. The distinct beads may differ in any suitable aspect(s), such as size, shape, an associated code, and/or material carried by the beads. In some embodiments, the aspect may identify the associated material. Codes are described further in Section XII below.

[0173] Vesicles

[0174] Particles may be vesicles. Vesicles generally comprise any noncellularly derived particle that is defined by a lipid envelope. Vesicles may include any suitable components in their envelope or interior portions. Suitable components may include compounds, polymers, complexes, mixtures, aggregates, and/or particles, among others. Exemplary components may include proteins, peptides, small compounds, drug candidates, receptors, nucleic acids, ligands, and/or the like.

[0175] Input Mechanisms

[0176] Overview

[0177] Microfluidic systems may include one or more input mechanisms that interface with the microfluidic network(s). An input mechanism generally comprises any suitable mechanism for inputting material(s) (e.g., particles, fluid, and/or reagents) to a microfluidic network of a microfluidic chip, including selective (that is, component-by-component) and/or bulk mechanisms.

[0178] Internal/External Sources

[0179] The input mechanism may receive material from internal sources, that is, reservoirs that are included in a microfluidic chip, and/or external sources, that is, reservoirs that are separate from, or external to, the chip.

[0180] Input mechanisms that input materials from internal sources may use any suitable receptacle to store and dispense the materials. Suitable receptacles may include a void formed in the chip. Such voids may be directly accessible from outside the chip, for example, through a hole extending from fluidic communication with a fluid network to an external surface of the chip, such as the top surface. The receptacles may have a fluid capacity that is relatively large compared to the fluid capacity of the fluid network, so that they are not quickly exhausted. For example, the fluid capacity may be at least about 1, 5, 10, 25, 50, or 100 μL. Accordingly, materials may be dispensed into the receptacles using standard laboratory equipment, if desired, such as micropipettes, syringes, and the like.

[0181] Input mechanisms that input materials from external sources also may use any suitable receptacle and mechanism to store and dispense the materials. However, if the external sources input materials directly into the fluid network, the external sources may need to interface effectively with the fluid network, for example, using contact and/or noncontact dispensing mechanisms. Accordingly, input mechanisms from external sources may use capillaries or needles to direct fluid precisely into the fluid network. Alternatively, or in addition, input mechanisms from external sources may use a noncontact dispensing mechanism, such as “spitting,” which may be comparable to the action of an inkjet printer. Furthermore, input mechanisms from external sources may use ballistic propulsion of particles, for example, as mediated by a gene gun.

[0182] Facilitating Mechanisms

[0183] The inputting of materials into the microfluidics system may be facilitated and/or regulated using any suitable facilitating mechanism. Such facilitating mechanisms may include gravity flow, for example, when an input reservoir has greater height of fluid than an output reservoir. Facilitating mechanisms also may include positive pressure to push materials into the fluidic network, such as mechanical or gas pressure, or centrifugal force; negative pressure at an output mechanism to draw fluid toward the output mechanism; and/or a positioning mechanism acting within the fluid network. The positioning mechanism may include a pump and/or an electrokinetic mechanism. Positioning mechanisms are further described below, in Section V. In some embodiments, the facilitating mechanism may include a suspension mechanism to maintain particles such as cells in suspension prior to inputting, for example, as described in Example 7.

[0184] Positioning Mechanisms

[0185] Overview

[0186] Microfluidic systems may include one or more positioning mechanisms. A positioning mechanism generally comprises any mechanism for placing particles at preselected positions on the chip after inputting, for example, for retention, growth, treatment, and/or measurement, among others. Positioning mechanisms may be categorized without limitation in various ways, for example, to reflect their origins and/or operational principles, including direct and/or indirect, fluid-mediated and/or non-fluid-mediated, external and/or internal, and so on. These categories are not mutually exclusive. Thus, a given positioning mechanism may position a particle in two or more ways; for example, electric fields may position a particle directly (e.g., via electrophoresis) and indirectly (e.g., via electroosmosis).

[0187] The positioning mechanisms may act to define particle position longitudinally and/or transversely. The term “longitudinal position” denotes position parallel to or along the long axis of a microfluidic channel and/or a fluid flow stream within the channel. In contrast, the term “transverse position” denotes position orthogonal to the long axis of a channel and/or an associated main fluid flow stream. Both longitudinal and transverse positions may be defined locally, by equating “long axis” with “tangent” in curved channels.

[0188] The positioning mechanisms may be used alone and/or in combination. If used in combination, the mechanisms may be used serially (i.e., sequentially) and/or in parallel (i.e., simultaneously). For example, an indirect mechanism such as fluid flow may be used for rough positioning, and a direct mechanism such as optical tweezers may be used for final positioning (and/or subsequent retention, as described elsewhere).

[0189] The remainder of this section describes without limitation a variety of exemplary positioning mechanisms, sorted roughly as direct and indirect mechanisms.

[0190] Direct Positioning Mechanisms

[0191] Direct positioning mechanisms generally comprise any mechanisms in which a force acts directly on a particle(s) to position the particle(s) within a microfluidic network. Direct positioning mechanisms may be based on any suitable mechanism, including optical, electrical, magnetic, and/or gravity-based forces, among others. Optical positioning mechanisms use light to mediate or at least facilitate positioning of particles. Suitable optical positioning mechanisms include “optical tweezers,” which use an appropriately focused and movable light source to impart a positioning force on particles. Electrical positioning mechanisms use electricity to position particles. Suitable electrical mechanisms include “electrokinesis,” that is, the application of voltage and/or current across some or all of a microfluidic network, which may, as mentioned above, move charged particles directly (e.g., via electrophoresis) and/or indirectly, through movement of ions in fluid (e.g., via electroosmosis). Magnetic positioning mechanisms use magnetism to position particles based on magnetic interactions. Suitable magnetic mechanisms involve applying a magnetic field in or around a fluid network, to position particles via their association with ferromagnetic and/or paramagnetic materials in, on, or about the particles. Gravity-based positioning mechanisms use the force of gravity to position particles, for example, to contact adherent cells with a substrate at positions of cell culture.

[0192] Indirect Positioning Mechanisms

[0193] Indirect positioning mechanisms generally comprise any mechanisms in which a force acts indirectly on a particle(s), for example, via fluid, to move the particle(s) within a microfluidic network, longitudinally and/or transversely.

[0194] Longitudinal Indirect Positioning Mechanisms

[0195] Longitudinal indirect positioning mechanisms generally may be created and/or regulated by fluid flow along channels and/or other passages. Accordingly, longitudinal positioning mechanisms may be facilitated and/or regulated by valves and/or pumps that regulate flow rate and/or path. In some cases, longitudinal positioning mechanisms may be facilitated and/or regulated by electroosmotic positioning mechanisms. Alternatively, or in addition, longitudinal positioning mechanisms may be input-based, that is, facilitated and/or regulated by input mechanisms, such as pressure or gravity-based mechanisms, including a pressure head created by unequal heights of fluid columns.

[0196] Transverse Indirect Positioning Mechanisms

[0197] Transverse indirect positioning mechanisms generally may be created and/or regulated by fluid flow streams at channel junctions, laterally disposed regions of reduced fluid flow, and/or channel bends. Channel junctions may be unifying sites or dividing sites, based on the number of channels that carry fluid to the sites relative to the number that carry fluid away from the sites. Transverse indirect positioning mechanisms may be based on laminar flow, stochastic partitioning, and/or centrifugal force, among others.

[0198] Laminar Flow-Based Transverse Positioning Mechanisms

[0199] Transverse positioning of particles and/or reagents in a microfluidic system may be mediated at least in part by a laminar flow-based mechanism. Laminar flow-based mechanisms generally comprise any positioning mechanism in which the position of an input flow stream within a channel is determined by the presence, absence, and/or relative position(s) of additional flow streams within the channel. Such laminar flow-based mechanisms may be defined by a channel junction(s) that is a unifying site, at which inlet flow streams from two, three, or more channels, flowing toward the junction, unify to form a smaller number of outlet flow streams, preferably one, flowing away from the junction. Due to the laminar flow properties of flow streams on a microfluidic scale, the unifying site may maintain the relative distribution of inlet flow streams after they unify as laminar outlet flow streams. Accordingly, particles and/or reagents may remain localized to any selected one or more of the laminar flow streams, based on which inlet channels carry particles and/or reagents, thus positioning the particles and/or reagents transversely.

[0200] The relative size (or flow rate) and position of each inlet flow stream may determine both transverse position and relative width of flow streams that carry particles and/or reagents. For example, an inlet flow stream for particles/reagents that is relatively small (narrow), flanked by two larger (wider) flow streams, may occupy a narrow central position in a single outlet channel. By contrast, an inlet flow stream for particles/reagents that is relatively large (wide), flanked by a comparably sized flow stream and a smaller (narrower) flow stream, may occupy a wider position that is biased transversely toward the smaller flow stream. In either case, the laminar flow-based mechanism may be called a focusing mechanism, because the particles/reagents are “focused” to a subset of the cross-sectional area of outlet channels. Laminar flow-based mechanisms may be used to individually address particles and/or reagents to plural distinct retention sites. Exemplary laminar flow-based positioning mechanisms are further described below, in Examples 2-4, 7, 9, 11, and 26, among others.

[0201] A laminar flow-based mechanism may be a variable mechanism to vary the transverse position of particles/reagents. As described above, the relative contribution of each inlet flow stream may determine the transverse position of particles/reagents flow streams. Altered flow of any inlet flow stream may vary its contribution to the outlet flow stream(s), shifting particles/reagents flow streams accordingly. In an extreme case, referred to as a perfusion mechanism, a reagent (or particle) flow stream may be moved transversely, either in contact with, or spaced from, retained particles (reagents), based on presence or absence of flow from an adjacent inlet flow stream. Such a mechanism also may be used to effect variable or regulated transverse positioning of particles, for example, to direct particles to retention sites having different transverse positions. Exemplary variable or regulated transverse positioning mechanisms, referred to as perfusion mechanisms, are further described below, in Examples 2-4, 6, 7, 11, and 26, among others.

[0202] Stochastic Transverse Positioning Mechanisms

[0203] Transverse positioning of particles and/or reagents in a microfluidic system may be mediated at least in part by a stochastic (or portioned flow) positioning mechanism. Stochastic transverse positioning mechanisms generally comprise any positioning mechanism in which an at least partially randomly selected subset of inputted particles or reagent is distributed laterally away from a main flow stream to a region of reduced fluid flow within a channel (or, potentially, to a distinct channel). The region of reduced flow may promote particle retention, treatment, detection, minimize particle damage, and/or promote particle contact with a substrate. Stochastic positioning mechanisms may be determined by dividing flow sites and/or locally widened channels, among others.

[0204] Dividing flow sites may effect stochastic positioning by forming regions of reduced fluid flow rate. Dividing flow sites generally include any channel junction at which inlet flow streams from one (preferably) or more inlet channels are divided into a greater number of outlet channels, including two, three, or more, channels. Such dividing sites may deliver a subset of particles, which may be selected stochastically and/or based on a property of the particles (such as mass), to a region of reduced flow rate or quasi-stagnant flow formed at or near the junction. The fraction of particles represented by the subset may be dependent upon the relative flow directions of the outlet channels relative to the inlet channels. These flow directions may be generally orthogonal to an inlet flow stream, being directed in opposite directions, to form a “T-junction.” Alternatively, outlet flow directions may form angles of less than and/or greater than 90°. Exemplary reduced-velocity, dividing-flow positioning mechanisms are further described below, in Examples 1, 2, 3, 4, 6, 7, and 26, among others.

[0205] The dividing-flow positioning mechanism, with two or more outlet channels, may be used as a portioned-flow mechanism. Specifically, fluid, particles, and/or reagents carried to the channel junction may be portioned according to fluid flow through the two or more outlet channels. Accordingly, the fractional number or volume of particles or reagent that enters the two or more channels may be regulated by the relative sizes of the channels and/or the flow rate of fluid through the channels, which in turn may be regulated by valves, or other suitable flow regulatory-mechanisms. In a first set of embodiments, outlet channels may be of very unequal sizes, so that only a small fraction of particle and/or reagents are directed to the smaller channel. In a second set of embodiments, valves may be used to forms desired dilutions of reagents. In a third set of embodiments, valves may be used to selectively direct particles to one of two or more fluid paths. Examples of these three sets of embodiments are further described below, in Examples 11, 8, and 7, respectively.

[0206] Locally widened channels may promote stochastic positioning by producing regions of decreased flow rate lateral to a main flow stream. The decreased flow rate may deposit a subset of inputted particles at a region of decreased flow rate. Such widened channels may include nonlinear channels that curve or bend at an angle. Alternatively, or in addition, widened regions may be formed by recesses formed in a channel wall(s), chambers that intersect channels, and/or the like, particularly at the outer edge of a curved or bent channel. Exemplary locally widened channels that promote stochastic transverse positioning are described further in Example 10.

[0207] Centrifugal-force-based Transverse Positioning Mechanisms

[0208] Transverse positioning of particles and/or reagents also may be mediated at least in part by a centrifugal positioning mechanism. In centrifugal positioning mechanisms, particles may experience a centrifugal force determined by a change in velocity, for example, by moving through a bend in a fluid path. Size and/or density of particles may determine the rate of velocity change, distributing distinct sizes and/or densities of particle to distinct transverse positions. Exemplary centrifugal positioning mechanisms are further described below, in Example 9.

[0209] Retention Mechanisms

[0210] Overview

[0211] Microfluidic systems may include one or more retention mechanisms. A retention mechanism generally comprises any suitable mechanism for retaining (or holding, capturing, or trapping) particles at preselected positions or regions of microfluidic networks, including single or plural mechanisms, operating in series and/or in parallel. Retention mechanisms may act to overcome the positioning force exerted by fluid flow. Furthermore, retention mechanisms, also referred to as capture or trapping mechanisms, may retain any suitable number of particles, including single particles or groups/populations of particles. Suitable retention mechanisms may be based on physical barriers coupled with flow, chemical interactions, vacuum forces, fluid flow in a loop, gravity, centrifugal forces, magnetic forces, electrical forces, and/or optically generated forces, among others.

[0212] Retention mechanisms may be selective or nonselective. Selective mechanisms may be fractionally selective, that is, retaining less than all (a subset of) inputted particles. Fractionally selective mechanisms may rely at least in part on stochastic positioning mechanisms, such as that exemplified in Example 2. Alternatively, or in addition, selective mechanisms may be particle-dependent, that is, retaining particles based on one or more properties of the inputted particle, such as size, surface chemistry, density, magnetic character, electrical charge, optical property (such as refractive index), and/or the like.

[0213] Physical Barrier-Based Retention Mechanisms

[0214] Retention mechanisms may be based at least partially on particle contact with any suitable physical barrier(s) disposed in a microfluidic network. Such particle-barrier contact generally restricts longitudinal particle movement along the direction of fluid flow, producing flow-assisted retention. Flow-assisted particle-barrier contact also may restrict side-to-side/orthogonal (transverse) movement. Suitable physical barriers may be formed by protrusions that extend inward from any portion of a channel or other passage (that is, walls, roof, and/or floor). For example, the protrusions may be fixed and/or movable, including columns, posts, blocks, bumps, walls, and/or partially/completely closed valves, among others. Some physical barriers, such as valves, may be movable or regulatable. Alternatively, or in addition, a physical barrier may be defined by a recess(es) formed in a channel or other passage, or by a fluid-permeable membrane. Other physical barriers may be formed based on the cross-sectional dimensions of passages. For example, size-selective channels may retain particles that are too large to enter the channels. (Size-selective channels also may be referred to as filter channels, microchannels, or particle-restrictive or particle-selective channels.)

[0215] Further aspects of physical barriers and size-selective channels are described below in Section XIII, and in the patent applications listed in the Cross-References, which are incorporated herein by reference.

[0216] Chemical Retention Mechanisms

[0217] Chemical retention mechanisms may retain particles based on chemical interactions. The chemical interactions may be covalent and/or noncovalent interactions, including ionic, electrostatic, hydrophobic, van der Waals, and/or metal coordination interactions, among others. Chemical interactions may retain particles selectively and/or nonselectively. Selective and nonselective retention may be based on specific and/or nonspecific chemical interactions between particles and passage surfaces.

[0218] Chemical interactions may be specific. Specific mechanisms may use specific binding pairs (SBPs), for example, with first and second SBP members disposed on particles and passage surfaces, respectively. Exemplary SBPs may include biotin/avidin, antibody/antigen, lectin/carbohydrate, etc. These and additional exemplary SBPs are listed below in Table 1, with the designations of first and second being arbitrary. SBP members may be disposed locally within microfluidic networks before, during and/or after formation of the networks. For example, surfaces of a substrate and/or a fluid layer component may be locally modified by adhesion/attachment of a SBP member before the substrate and fluid layer component are joined. Alternatively, or in addition, an SBP member may be locally associated with a portion of a microfluidic network after the network has been formed, for example, by local chemical reaction of the SBP member with the network (such as catalyzed by local illumination with light). 1

TABLE 1
Representative Specific Binding Pairs
First SBP Member Second SBP Member
Antigen antibody
Biotin avidin or streptavidin
Carbohydrate lectin or carbohydrate receptor